Molecular Classification
Other
Other Names
Blood circulation activation (TCM), Blood stasis removal (TCM), Huoxue Huayu (活血化瘀), TCM blood-moving therapy
Disease Roles
Cardiovascular diseaseDiabetes complicationsMicrovascular disease

Blood circulation promotion via multi-herbal synergy in TCM theory Overview

"Blood circulation promotion via multi-herbal synergy in TCM theory" is a traditional Chinese medicine therapeutic concept, not a single molecule, receptor, or gene. It refers to the use of multiple herbs—each with different mechanisms—to synergistically improve blood circulation, reduce blood stasis (obstruction/sluggishness of blood), and treat related disorders such as cardiovascular diseases, diabetes complications, and vascular dysfunction. While mechanism studies have identified endpoints such as antiplatelet activity, vasorelaxation, endothelial protection, and Na⁺/K⁺-ATPase inhibition, this therapeutic principle is not reducible to any one molecular target[1][3][4][5]. Rather, it encompasses a polypharmacological, system-level intervention characteristic of TCM formulations. This entry does not map to a canonical drug target and should be flagged as improper or non-specific for structured target data.

Mechanism of Action

Antiplatelet aggregation (e.g., inhibition of TXA₂/PGI₂ imbalance); Vasodilation; Protection of vascular endothelium and basement membrane; Inhibition of Na⁺/K⁺-ATPase (through steroid-like compounds); Modulation of calcium signaling in myocardium; Inhibition of advanced glycation end-product formation; Antioxidant and lipid-lowering effects

Biological Functions

Blood flow regulation
Hemorheology modulation
Antiplatelet activity
Vascular protection
Other

Disease Associations

Cardiovascular disease
Diabetes complications
Microvascular disease
Thrombosis
Atherosclerosis
Other

Safety Considerations

  • Herb-drug interactions (e.g., additive antiplatelet effect)
  • Bleeding risk when combined with anticoagulants
  • Variability in herbal compound potency/quality
  • Null (no molecule-specific or receptor-specific toxicities)

Interacting Drugs

Salvia miltiorrhiza (Danshen)
Panax notoginseng (Sanqi)
Angelica sinensis (Dong quai)
Ligusticum wallichii (Chuanxiong)
Carthamus tinctorius (Safflower)
Caulis Spatholobi
Leech extracts
Multiple multi-herbal TCM formulas (e.g., Taohongsiwu Decoction, Honghua injection)

Associated Biomarkers

Biomarker
Platelet aggregation rate
TXB₂ (thromboxane B2) concentration
6-keto-PGF1α (prostacyclin metabolite) concentration
Hemorheological markers (e.g., blood viscosity)
Null (no canonical drug target biomarker as for molecular receptors)